Which biochemical marker is NOT included in establishing the diagnosis of preeclampsia?

Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to other organ systems, often the liver and kidneys. The diagnosis of preeclampsia typically involves the assessment of several biochemical markers that indicate organ function and overall health status.

Uric acid, creatinine, and liver enzymes are all relevant in the context of preeclampsia. Elevated levels of uric acid can indicate renal impairment associated with the condition. Creatinine is a key marker of kidney function, and elevated levels suggest potential kidney injury often linked to the complications of preeclampsia. Liver enzymes, particularly elevated levels of AST and ALT, may indicate liver dysfunction and are critical in diagnosing severe cases of preeclampsia or HELLP syndrome.

However, the marker that is not typically included in establishing the diagnosis of preeclampsia is Put. This marker lacks clinical relevance in the context of this condition and does not provide information about the organ dysfunction or other physiological changes associated with preeclampsia. Therefore, while uric acid, creatinine, and liver enzymes contribute essential information for a comprehensive evaluation, Put does not hold the same significance and is not utilized in the diagnostic criteria for preeclampsia